GlassScriptPhysician profile
Natalie Poole
NPI 1457905614
$5,829.47
in general payments reported to CMS, 2019-2025
12 companies · $4,171 in 2025
The $4,171 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.57 · 2023: $191 · 2024: $1,432 · 2025: $4,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $2,782 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $2,781.75 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,547.16 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $956.90 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $272.30 | 2023-2025 | Rexulti, Abilify Mycite, Abilify Maintena |
| Lundbeck LLC | $225.42 | 2023-2025 | Rexulti |
| Axsome Therapeutics, INC. | $189.15 | 2024-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $177.04 | 2025 | Fanapt, Hetlioz |
| Supernus Pharmaceuticals, INC. | $171.32 | 2023-2024 | Qelbree, Qelbree |
| Alkermes, INC. | $156.81 | 2024-2025 | Lybalvi, Aristada |
| Takeda Pharmaceuticals U.S.A., INC. | $54.98 | 2023-2024 | Trintellix |
| Sage Therapeutics, LLC | $37.08 | 2024 | |
| Tempus Ai, INC | $22.82 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $18.49 | 2024 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Poole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.